homovanillic acid has been researched along with Dyskinesia, Medication-Induced in 68 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous studies have variably reported the efficacy of apomorphine in treatment of schizophrenia and tardive dyskinesia." | 9.05 | Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses. ( Davis, BM; Davis, KL; Horvath, TB; Kendler, KS; Levy, MI; Mathé, AA; Mohs, RC; Trigos, G, 1984) |
| "Measurement of plasma prolactin (PRL) concentration and plasma homovanillic acid (HVA) concentration was performed in 24 patients with schizophrenia during maintenance haloperidol treatment." | 7.68 | Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia. ( Csernansky, JG; Newcomer, JW; Riney, SJ; Vinogradov, S, 1992) |
| "Plasma prolactin concentration (pPRL), plasma homovanillic acid concentration (pHVA), and symptomatology were measured in 24 male subjects with schizophrenia during maintenance haloperidol treatment." | 5.07 | Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease. ( Csernansky, JG; Newcomer, JW; Riney, SJ; Vinogradov, S, 1992) |
| "Previous studies have variably reported the efficacy of apomorphine in treatment of schizophrenia and tardive dyskinesia." | 5.05 | Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses. ( Davis, BM; Davis, KL; Horvath, TB; Kendler, KS; Levy, MI; Mathé, AA; Mohs, RC; Trigos, G, 1984) |
| "Measurement of plasma prolactin (PRL) concentration and plasma homovanillic acid (HVA) concentration was performed in 24 patients with schizophrenia during maintenance haloperidol treatment." | 3.68 | Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia. ( Csernansky, JG; Newcomer, JW; Riney, SJ; Vinogradov, S, 1992) |
| "Plasma homovanillic acid (pHVA) levels were measured in 16 chronically ill patients with schizophrenia who also suffered from tardive dyskinesia, and in a group of 14 chronically ill patients with schizophrenia who did not have tardive dyskinesia." | 3.68 | Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia. ( Barbato, G; de Bartolomeis, A; Monteleone, P; Muscettola, G; Pickar, D, 1990) |
| " This review summarises that available pharmacokinetic data involving levodopa, especially as it relates to therapeutic response of parkinsonian patients." | 2.35 | Clinical pharmacokinetics of levodopa in parkinson's disease. ( Bianchine, JR; Shaw, GM, 1976) |
| "Levodopa (l-DOPA, l-3,4-dihydroxyphenylalanine) is the most effective drug in the symptomatic treatment of Parkinson's disease (PD), but chronic use initiates a maladaptive process leading to l-DOPA-induced dyskinesia (LID)." | 1.46 | Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia. ( Andersen, AD; Binzer, M; Blaabjerg, M; Gramsbergen, JBP; Kamal, A; Kjaer, TW; Stenager, E; Thagesen, H, 2017) |
| " Dosage of concurrent neuroleptics was fixed at least 3 weeks prior to the trial and was unchanged throughout the study period." | 1.29 | B-HT 920, a dopamine D2 agonist, in the treatment of negative symptoms of chronic schizophrenia. ( Inoue, T; Koyama, T; Matsubara, S; Ohmori, T; Yamashita, I, 1993) |
| " Chronic administration of ceruletide (160 micrograms." | 1.29 | Effect of chronic ceruletide treatment on dopaminergic neurotransmitters, receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile. ( Asanuma, M; Hirata, H; Mori, A; Ogawa, N; Ota, Z, 1993) |
| "In ongoing studies of chronic administration of neuroleptics to monkeys (Cebus apella) and rats, the regional distribution of glutamic acid decarboxylase (GAD) and brain levels of homovanillic acid were examined." | 1.27 | Experimental tardive dyskinesia. ( Gunne, LM; Häggström, JE, 1985) |
| "Pergolide mesylate is a potent dopamine agonist that is being evaluated clinically in Parkinson disease, hyperprolactinemia, and other diseases." | 1.26 | Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia. ( Clemens, JA; Fuller, RW; Hynes, MD, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (60.29) | 18.7374 |
| 1990's | 19 (27.94) | 18.2507 |
| 2000's | 5 (7.35) | 29.6817 |
| 2010's | 3 (4.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morin, N | 1 |
| Morissette, M | 1 |
| Grégoire, L | 1 |
| Di Paolo, T | 3 |
| Andersen, AD | 1 |
| Blaabjerg, M | 1 |
| Binzer, M | 1 |
| Kamal, A | 1 |
| Thagesen, H | 1 |
| Kjaer, TW | 1 |
| Stenager, E | 1 |
| Gramsbergen, JBP | 1 |
| Yabe, H | 1 |
| Choudhury, ME | 1 |
| Kubo, M | 1 |
| Nishikawa, N | 1 |
| Nagai, M | 1 |
| Nomoto, M | 1 |
| Kim, ST | 1 |
| Son, HJ | 1 |
| Choi, JH | 1 |
| Ji, IJ | 1 |
| Hwang, O | 1 |
| Buck, K | 1 |
| Ferger, B | 1 |
| Bishnoi, M | 1 |
| Chopra, K | 1 |
| Kulkarni, SK | 1 |
| Ogawa, T | 1 |
| Nagao, T | 3 |
| Kashiwabara, K | 1 |
| Fujiwara, Y | 1 |
| Harada, T | 1 |
| Otsuki, S | 3 |
| Kolbe, H | 1 |
| Clow, A | 1 |
| Jenner, P | 1 |
| Marsden, CD | 1 |
| Tripodianakis, J | 1 |
| Markianos, M | 1 |
| Garelis, E | 1 |
| Kirch, D | 1 |
| Hattox, S | 1 |
| Bell, J | 1 |
| Murphy, R | 1 |
| Freedman, R | 1 |
| Moore, DC | 2 |
| Glazer, WM | 4 |
| Bowers, MB | 5 |
| Heninger, GR | 2 |
| Naftolin, F | 1 |
| MacLusky, NJ | 1 |
| Arató, M | 2 |
| Bagdy, G | 3 |
| Perényi, A | 3 |
| Béla, A | 1 |
| Jeste, DV | 3 |
| Doongaji, DR | 1 |
| Linnoila, M | 2 |
| Akiyama, K | 1 |
| Yamamoto, M | 1 |
| Fujimoto, A | 1 |
| Ebara, T | 1 |
| Sato, M | 2 |
| Levy, MI | 2 |
| Davis, BM | 2 |
| Mohs, RC | 2 |
| Kendler, KS | 2 |
| Mathé, AA | 2 |
| Trigos, G | 2 |
| Horvath, TB | 2 |
| Davis, KL | 2 |
| Cutler, NR | 1 |
| Kaufmann, CA | 1 |
| Karoum, F | 1 |
| Johns, CA | 1 |
| Fuller, RW | 1 |
| Clemens, JA | 1 |
| Hynes, MD | 1 |
| Szymanski, S | 1 |
| Lieberman, J | 2 |
| Pollack, S | 2 |
| Munne, R | 1 |
| Safferman, A | 1 |
| Kane, J | 2 |
| Kronig, M | 1 |
| Cooper, T | 3 |
| Fornai, F | 1 |
| Alessandri, MG | 1 |
| Saginario, A | 1 |
| Vaglini, F | 1 |
| Corsini, GU | 2 |
| Lieberman, JA | 1 |
| Alvir, J | 1 |
| Geisler, S | 1 |
| Ramos-Lorenzi, J | 1 |
| Woerner, M | 1 |
| Novacenko, H | 1 |
| Kane, JM | 1 |
| Ohmori, T | 1 |
| Koyama, T | 1 |
| Inoue, T | 1 |
| Matsubara, S | 1 |
| Yamashita, I | 1 |
| See, RE | 1 |
| Hirata, H | 1 |
| Ogawa, N | 2 |
| Asanuma, M | 2 |
| Ota, Z | 1 |
| Mori, A | 1 |
| Northoff, G | 1 |
| Wenke, J | 1 |
| Demisch, L | 1 |
| Eckert, J | 1 |
| Gille, B | 1 |
| Pflug, B | 1 |
| Yamada, K | 1 |
| Kanba, S | 1 |
| Ohnishi, K | 1 |
| Ashikari, I | 1 |
| Yagi, G | 1 |
| Asai, M | 1 |
| Sweet, RA | 1 |
| Pollock, BG | 1 |
| Mulsant, BH | 1 |
| Rosen, J | 1 |
| Lo, KH | 1 |
| Yao, JK | 1 |
| Henteleff, RA | 1 |
| Mazumdar, S | 1 |
| Andia, I | 1 |
| Zumarraga, M | 1 |
| Zabalo, MJ | 1 |
| Bulbena, A | 1 |
| Davila, R | 1 |
| Iida, K | 1 |
| Iwata, E | 1 |
| Asanuma, SN | 1 |
| Gómez-Vargas, M | 1 |
| Miyazaki, I | 1 |
| Nakanishi, T | 1 |
| Iacono, RP | 1 |
| Nahab, FB | 1 |
| Nahab, FH | 1 |
| Mohanakumar, KP | 1 |
| Muralikrishnan, D | 1 |
| Thomas, B | 1 |
| Sayers, AC | 2 |
| Bürki, HR | 3 |
| Ruch, W | 2 |
| Asper, H | 2 |
| Winsberg, BG | 2 |
| Hurwic, MJ | 2 |
| Perel, J | 1 |
| Sverd, J | 1 |
| Klutch, A | 1 |
| Roccatagliata, G | 2 |
| Albano, C | 2 |
| Besio, G | 1 |
| Ohshimo, T | 1 |
| Mitsunobu, K | 1 |
| Costentin, J | 1 |
| Klawans, HL | 1 |
| Goetz, C | 1 |
| Nausieda, PA | 1 |
| Weiner, WJ | 1 |
| Cocito, L | 1 |
| Maffini, M | 1 |
| Moore, D | 1 |
| Tarsy, D | 1 |
| Bianchine, JR | 1 |
| Shaw, GM | 1 |
| Lhermitte, F | 1 |
| Rosa, A | 1 |
| Comoy, E | 1 |
| Soininen, H | 1 |
| Laulumaa, V | 1 |
| Helkala, EL | 1 |
| Hartikainen, P | 1 |
| Riekkinen, PJ | 1 |
| Newcomer, JW | 2 |
| Riney, SJ | 2 |
| Vinogradov, S | 2 |
| Csernansky, JG | 2 |
| Lohr, JB | 1 |
| Kuczenski, R | 1 |
| Bracha, HS | 1 |
| Moir, M | 1 |
| Bankiewicz, KS | 1 |
| Plunkett, RJ | 1 |
| Mefford, I | 1 |
| Kopin, IJ | 2 |
| Oldfield, EH | 1 |
| Johansson, PE | 1 |
| Terenius, L | 1 |
| Häggström, JE | 2 |
| Gunne, L | 1 |
| Jolicoeur, FB | 1 |
| Rivest, R | 1 |
| Drumheller, A | 1 |
| Muscettola, G | 1 |
| Barbato, G | 1 |
| de Bartolomeis, A | 1 |
| Monteleone, P | 1 |
| Pickar, D | 1 |
| Saito, T | 1 |
| Ishizawa, H | 1 |
| Tsuchiya, F | 1 |
| Ozawa, H | 1 |
| Takahata, N | 1 |
| Lu, RB | 1 |
| Ko, HC | 1 |
| Lin, WL | 1 |
| Lin, YT | 1 |
| Ho, SL | 1 |
| Johns, C | 1 |
| Charney, DS | 1 |
| Frecska, E | 2 |
| Degrell, I | 1 |
| Mogyorosy, Z | 1 |
| Stahl, SM | 1 |
| Faull, KF | 1 |
| Barchas, JD | 1 |
| Berger, PA | 1 |
| Gunne, LM | 1 |
| Cross, AJ | 1 |
| Crow, TJ | 1 |
| Ferrier, IN | 1 |
| Johnson, JA | 1 |
| Johnstone, EC | 1 |
| Owen, F | 1 |
| Owens, DG | 1 |
| Poulter, M | 1 |
| Révai, K | 1 |
| Kirch, DG | 1 |
| Jaskiw, G | 1 |
| Weinberger, DR | 1 |
| Wyatt, RJ | 1 |
| Lepore, V | 1 |
| Di Reda, N | 1 |
| Defazio, G | 1 |
| Pedone, D | 1 |
| Giovine, A | 1 |
| Lanzi, C | 1 |
| Tartaglione, B | 1 |
| Livrea, P | 1 |
| Bédard, PJ | 2 |
| Boucher, R | 2 |
| Daigle, M | 1 |
| Pintus, S | 1 |
| Chiueh, CC | 1 |
| Weiss, JF | 1 |
| Falardeau, P | 1 |
| Bouchard, S | 1 |
2 reviews available for homovanillic acid and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
[Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].
Topics: Acetylcholine; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Behavior; Corpus Stria | 1979 |
Clinical pharmacokinetics of levodopa in parkinson's disease.
Topics: Carboxy-Lyases; Cardiovascular Diseases; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Dru | 1976 |
11 trials available for homovanillic acid and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
CSF monoamine metabolism in patients with tardive dyskinesia: effect of oxypertine and hydroxyzine pamoate.
Topics: Biogenic Amines; Clinical Trials as Topic; Cyclic AMP; Cyclic GMP; Dyskinesia, Drug-Induced; Female; | 1983 |
Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.
Topics: Adult; Apomorphine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Growth Hormone; Homovanillic | 1984 |
Apomorphine and schizophrenia.
Topics: Adult; Apomorphine; Dyskinesia, Drug-Induced; Homovanillic Acid; Hormones; Humans; Male; Middle Aged | 1984 |
The dopamine-serotonin relationship in clozapine response.
Topics: Adolescent; Adult; Antipsychotic Agents; Clozapine; Dopamine; Drug Resistance; Dyskinesia, Drug-Indu | 1993 |
Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia.
Topics: Adolescent; Adult; Blinking; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Follow-Up Studie | 1994 |
Catatonia: short-term response to lorazepam and dopaminergic metabolism.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Anxiety; Catatonia; Depressive Disorder; Dopamine; Dyskin | 1995 |
Association of plasma homovanillic acid with behavioral symptoms in patients diagnosed with dementia: a preliminary report.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Behavior; Dyskinesia, Drug-Induced | 1997 |
Differential effect of haloperidol and clozapine on plasma homovanillic acid in elderly schizophrenic patients with or without tardive dyskinesia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Female; Haloperi | 1998 |
Tardive dyskinesia: a clinical test of the supersensitivity hypothesis.
Topics: Adult; Aged; Clinical Trials as Topic; Cyclic AMP; Depression; Dyskinesia, Drug-Induced; Female; Hom | 1979 |
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease.
Topics: Adult; Aged; Biomarkers; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Ind | 1992 |
Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.
Topics: Adolescent; Adult; Antipsychotic Agents; Brain; Catecholamines; Clinical Trials as Topic; Double-Bli | 1988 |
55 other studies available for homovanillic acid and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; | 2015 |
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aging; Antiparkinson Agents; Catecholamines; Dopamine; | 2017 |
Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Anticonvulsan | 2009 |
Vertical grid test and modified horizontal grid test are sensitive methods for evaluating motor dysfunctions in the MPTP mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biomechanical Phenomena; Chromatography, High | 2010 |
Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic-L-Amino-Acid Decarboxylases; Behavior, Animal; Ben | 2008 |
Modulatory effect of neurosteroids in haloperidol-induced vacuous chewing movements and related behaviors.
Topics: Animals; Behavior, Animal; Catalase; Corpus Striatum; Dehydroepiandrosterone Sulfate; Dopamine; Dose | 2008 |
Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid.
Topics: Adult; Aged; Cyclic AMP; Cyclic GMP; Cyproheptadine; Dyskinesia, Drug-Induced; Female; Homovanillic | 1984 |
Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Dopamine; Dyskinesia, Drug-Induced; Erythrocyt | 1981 |
Neurochemical studies on tardive dyskinesia. I. Urinary homovanillic acid and plasma prolactin.
Topics: Aged; Antipsychotic Agents; Dopamine; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Male; Mid | 1983 |
Plasma homovanillic acid and tardive dyskinesia during neuroleptic maintenance and withdrawal.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Male; Ment | 1983 |
Tardive dyskinesia and plasma homovanillic acid.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Brain; Dopamine; Dyskinesia, Drug-Induced; Female; H | 1983 |
The relationship of circulating estradiol to tardive dyskinesia in men and postmenopausal women.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Estradiol; Female; Homovanillic Acid; Humans; Male; | 1983 |
Comparative neurochemical investigation of tardive dyskinesia and neuroleptic-induced chronic parkinsonism.
Topics: Adult; Antipsychotic Agents; Cyclic AMP; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Male; | 1984 |
Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Homovan | 1984 |
Low-dose apomorphine and bromocriptine in neuroleptic-induced movement disorders.
Topics: Adult; Apomorphine; Bromocriptine; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Male | 1983 |
Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corticosterone; Dopamine; Dose-Response Relationship | 1982 |
beta,beta'-Iminodipropionitrile-induced persistent dyskinetic syndrome in mice is transiently modified by MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Biogenic Monoamines; Cerebr | 1993 |
B-HT 920, a dopamine D2 agonist, in the treatment of negative symptoms of chronic schizophrenia.
Topics: Arousal; Azepines; Brain; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induce | 1993 |
Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Corpus Striatum; Dopamine; Dyskinesia, Drug-In | 1993 |
Effect of chronic ceruletide treatment on dopaminergic neurotransmitters, receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Blotting, Northern; Ceruletide; Corpus Striat | 1993 |
Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.
Topics: Adult; Aged; Amantadine; Chronic Disease; Dopamine Agents; Dose-Response Relationship, Drug; Drug Ad | 1997 |
Effects of repeated cyclosporin A administration on iminodipropionitrile-induced dyskinesia and TRE-/CRE-binding activities in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cell Nucleus; Corpus Striatum; Cyclic AMP; Cyclospor | 1998 |
Serotonergic decompensation in the akinetic expression of Parkinson's disease.
Topics: Brain; Chromatography, High Pressure Liquid; Dopamine; Dyskinesia, Drug-Induced; Homovanillic Acid; | 2000 |
Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Ani | 2000 |
Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.
Topics: Animals; Antipsychotic Agents; Atropine; Basal Ganglia Diseases; Clozapine; Corpus Striatum; Drug In | 1976 |
Neurochemistry of withdrawal emergent symptoms in children.
Topics: Antipsychotic Agents; Child; Cyclic AMP; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Hydrox | 1977 |
Neurochemistry of withdrawal emergent symptoms in children.
Topics: Antipsychotic Agents; Child; Child, Preschool; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; | 1978 |
[Late chronic dyskinesia from neuroleptic drugs (CSF and pharmacological data) (author's transl)].
Topics: Adult; Antipsychotic Agents; Brain; Dopamine; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; H | 1978 |
Biochemical methods for predicting the occurrence of tardive dyskinesia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Atropine; Caudate Nucleus; Dyskinesia, Drug-Induced; Hal | 1979 |
Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
Topics: Adult; Chronic Disease; Cyclic AMP; Cyclic GMP; Cyproheptadine; Dyskinesia, Drug-Induced; Female; Ho | 1979 |
Recent advances in the biochemical pharmacology of extrapyramidal movement disorders.
Topics: Animals; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Huntington | 1977 |
Interactions between central monoaminergic systems: dopamine-serotonin.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Depression; Dopamine; Dyskinesia, Drug-Induced; Female; H | 1979 |
Animal models for tardive dyskinesia: effects of thioridazine.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Homovanillic A | 1977 |
[Abnormal movements of patients with Parkinsonism treated with L-dopa and anomalies of dopamine metabolism].
Topics: Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Hum | 1977 |
Extrapyramidal signs in Alzheimer's disease: a 3-year follow-up study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Basal Ganglia Diseases; Dopamine; | 1992 |
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia.
Topics: Adult; Aged; Apomorphine; Brain; Dyskinesia, Drug-Induced; Haloperidol; Homovanillic Acid; Humans; M | 1992 |
Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; | 1990 |
Behavioral recovery from MPTP-induced parkinsonism in monkeys after intracerebral tissue implants is not related to CSF concentrations of dopamine metabolites.
Topics: Adrenal Medulla; Amnion; Animals; Brain Tissue Transplantation; Caudate Nucleus; Disease Models, Ani | 1990 |
Neuropeptide changes in a primate model (Cebus apella) for tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Cebus; Corpus Striatum; | 1990 |
Hypokinesia, rigidity, and tremor induced by hypothalamic 6-OHDA lesions in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Dyskinesia, Drug-Induced; Homovanillic Aci | 1991 |
Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia.
Topics: Aged; Chronic Disease; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Male; Middle Aged; Neuro | 1990 |
Neurochemical findings in the cerebrospinal fluid of schizophrenic patients with tardive dyskinesia and neuroleptic-induced parkinsonism.
Topics: Adult; Aged; Antipsychotic Agents; Catecholamines; Dopamine; Dyskinesia, Drug-Induced; Epinephrine; | 1986 |
CSF neurochemical study of tardive dyskinesia.
Topics: Acetylcholinesterase; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; | 1989 |
Clozapine pharmacology and tardive dyskinesia.
Topics: Adolescent; Adult; Clozapine; Dibenzazepines; Dyskinesia, Drug-Induced; Epinephrine; Female; Homovan | 1989 |
The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia.
Topics: Antipsychotic Agents; Brain; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; F | 1989 |
Multivariate analysis of monoamine indices in patients with chronic schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Brain; Dopamine; Dopamine beta-Hydroxylase; Dyskinesia, | 1989 |
CSF monamine metabolites in movement disorders and normal aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Dyskinesia, Drug-Induced; Dystonia; Female; Glycols; Ho | 1985 |
Experimental tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Brain; Cebus; Corpus Striatum; Disease Models, Animal; Drug Evaluatio | 1985 |
Chemical and structural changes in the brain in patients with movement disorder.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Antipsychotic Agents; Brain; Choline O-Acetyltransfer | 1985 |
Changes in mental condition, hyperkinesias and biochemical parameters after withdrawal of chronic neuroleptic treatment.
Topics: Adult; Antipsychotic Agents; Dopamine beta-Hydroxylase; Dyskinesia, Drug-Induced; Female; Homovanill | 1985 |
Is there a presynaptic tardive dyskinesia?
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Receptors, Dopamine | 1987 |
Dopaminomimetic action of diphenylhydantoin in rat striatum: effect on homovanillic acid and cyclic AMP levels.
Topics: Animals; Apomorphine; Corpus Striatum; Cyclic AMP; Dyskinesia, Drug-Induced; Haloperidol; Homovanill | 1985 |
Physiological doses of estradiol can increase lingual dyskinesia and cerebrospinal fluid homovanillic acid in monkeys.
Topics: Animals; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Estradiol; Female; Homovanillic Acid; | 1985 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amin | 1985 |
Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzaze | 1988 |